In the cutaneous melanoma PanCancer Atlas study (provisional), 11 of 27 samples (40.7%) with CTCFL mutations had lesions in one of the four MSI associated genes or the POLE or POLD1 genes. This evidence concerns the gene POLD1 and cutaneous melanoma.